Agno Pharma, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is SODIUM TETRADECYL SULFATE, with a corresponding US DMF Number 30900.
Remarkably, this DMF maintains an Active status since its submission on December 09, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 30, 2017, and payment made on December 28, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II